Concordia International Cash Flow - Annual (OTCMKTS:CXRXD)

Add to My Stocks
$18.45 $0 (0%) CXRXD stock closing price Sep 20, 2018 (Closing)
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow228.38M184.75M76.28M11.17M-
Net Increase (Decrease) in Assets Liabilities42.44M6.08M-67.53M-33.92M30.33M
Cash From (used in) Discontinued Operations-3.78M-2.41M--
Other Adjustments Net1.6B1.53B145.09M24.62M16.95M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-1.36M-1.88M7.95M-0.64M-0.1M
Acquisition Disposition of Subsidiaires-----59.25M
Increase (Decrease) in Investments-----
Other Cash Inflow (Outflow) from Investment Activities--29.71M-3.81B-294.08M-
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--811.37M59.35M39.06M
Issuance (Repayment) of Debt Securities-57.27M331.8M3.27B244.52M15.74M
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions--11.47M-10.06M-6.09M-
Other Cash from (used by) Financing Activities-315.1M-415.17M-276.39M-16.67M-2.4M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash18.87M-39.46M-9.42M--
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year397.91M155.44M42.77M42.89M-
Cash & Equivalents at Year End327.03M397.91M155.44M42.77M42.89M
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our BAUSCH HEALTH financial analysis

Key Financial Ratios For Concordia International Cash Flow

FCF margin

Annual Cash Flow Statements For Concordia International Corp Peers

BAUSCH HEALTH cash flow, DNIB UNWIND INC cash flow, COTINGA PHARMA cash flow, Telik cash flow, Polydex Pharma cash flow